Xorte logo

News Markets Groups

USA | Europe | Asia | World| Stocks | Commodities



Add a new RSS channel

 
 


Keywords

2021-10-24 01:05:00| Guardian Unlimited Business - more business news

With just a few years to turn the group around, the boss could do without a bellicose hedge fund breathing down her neckFew companies fit with the national zeitgeist quite like drugs giant GlaxoSmithKline. But few face the cocktail of pressures Dame Emma Walmsley, chief executive at Britains second-biggest drugmaker, is wrestling with. In post since 2017, she is under immense pressure from one of the most aggressive investors on the planet, New York-based hedge fund Elliott Management famous for chasing Argentina over its sovereign debts for more than decade.GSK, known for products ranging from HIV treatments to toothpaste, recently won plaudits when its malaria vaccine was approved by the World Health Organization. Chancellor Rishi Sunak boasted at the Tory party conference this month about building the UK into a science superpower. That vision depends on companies such as GSK converting its pipeline into drug successes. Continue reading...

Tags remedy malaise walmsley gsks

Category: News and Media

 

Latest from this category

03.12United States: U.S. Reintroduces COVID Travel Restrictions - Masuda, Funai, Eifert & Mitchell, Ltd.
03.12United States: OCC Advises Banks To Carefully Evaluate Venture Capital Fund Investments - Arnold & Porter
03.12United States: As States Seek To Expand Online Sports Betting, Federal District Court Invalidates Florida-Seminole Compact Permitting Sports Wagering Throughout Florida - WilmerHale
03.12United States: A Split Develops: Can Artificial Intelligence Invent Stuff? - Haug Partners
03.12Japan: Japan Closes Border In Response To Omicron Variant - Masuda, Funai, Eifert & Mitchell, Ltd.
03.12Canada: Multiple Lives For TRREB'S Multiple Listing Service: Claim For Copyright Infringement Survives Motion To Strike On Appeal - Bereskin & Parr LLP
03.12United States: Xryem: Pharmaceutical Settlement Acceleration Clause Found Anticompetitive Due To Risk Of "Profit Crushing Competition" - Haug Partners
03.12United States: California Passes Another Bill Addressing COVID-19 Reporting - Freeman Mathis & Gary
News and Media »

All news

03.12United States: U.S. Reintroduces COVID Travel Restrictions - Masuda, Funai, Eifert & Mitchell, Ltd.
03.12United States: OCC Advises Banks To Carefully Evaluate Venture Capital Fund Investments - Arnold & Porter
03.12United States: As States Seek To Expand Online Sports Betting, Federal District Court Invalidates Florida-Seminole Compact Permitting Sports Wagering Throughout Florida - WilmerHale
03.12United States: A Split Develops: Can Artificial Intelligence Invent Stuff? - Haug Partners
03.12Japan: Japan Closes Border In Response To Omicron Variant - Masuda, Funai, Eifert & Mitchell, Ltd.
03.12Canada: Multiple Lives For TRREB'S Multiple Listing Service: Claim For Copyright Infringement Survives Motion To Strike On Appeal - Bereskin & Parr LLP
03.12United States: Xryem: Pharmaceutical Settlement Acceleration Clause Found Anticompetitive Due To Risk Of "Profit Crushing Competition" - Haug Partners
03.12United States: California Passes Another Bill Addressing COVID-19 Reporting - Freeman Mathis & Gary
More »
Privacy policy . Copyright . Contact form .